MX2012014342A - Preparation of a levalbuterol salt. - Google Patents

Preparation of a levalbuterol salt.

Info

Publication number
MX2012014342A
MX2012014342A MX2012014342A MX2012014342A MX2012014342A MX 2012014342 A MX2012014342 A MX 2012014342A MX 2012014342 A MX2012014342 A MX 2012014342A MX 2012014342 A MX2012014342 A MX 2012014342A MX 2012014342 A MX2012014342 A MX 2012014342A
Authority
MX
Mexico
Prior art keywords
preparation
levalbuterol
salt
levalbuterol salt
bronchospasms
Prior art date
Application number
MX2012014342A
Other languages
Spanish (es)
Inventor
Lorenzo Pérez Pérez
Original Assignee
Glenmark Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glenmark Pharmaceuticals Ltd filed Critical Glenmark Pharmaceuticals Ltd
Priority to MX2012014342A priority Critical patent/MX2012014342A/en
Publication of MX2012014342A publication Critical patent/MX2012014342A/en

Links

Abstract

The present invention refers to a process for the preparation of a levalbuterol salt, pharmaceutical compositions containing the same and uses thereof in bronchospasms treatments in patients suffering from asthma or chronically obstructive pulmonary disease.
MX2012014342A 2012-12-07 2012-12-07 Preparation of a levalbuterol salt. MX2012014342A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2012014342A MX2012014342A (en) 2012-12-07 2012-12-07 Preparation of a levalbuterol salt.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012014342A MX2012014342A (en) 2012-12-07 2012-12-07 Preparation of a levalbuterol salt.

Publications (1)

Publication Number Publication Date
MX2012014342A true MX2012014342A (en) 2014-06-23

Family

ID=51795948

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012014342A MX2012014342A (en) 2012-12-07 2012-12-07 Preparation of a levalbuterol salt.

Country Status (1)

Country Link
MX (1) MX2012014342A (en)

Similar Documents

Publication Publication Date Title
WO2012110770A3 (en) Combination of glycopyrrolate and a beta2 -agonist
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
GB201209613D0 (en) New compounds
MX349004B (en) New compounds.
TN2015000278A1 (en) Autotaxin inhibitors
IN2014MN00986A (en)
GB201118656D0 (en) New compounds
MY179703A (en) Dry powder formulation comprising a phosphodiesterase inhibitor
MX2013012053A (en) Inhibitors of viral replication, their process of preparation and their therapeutical uses.
WO2013151665A3 (en) Modified polynucleotides for the production of proteins associated with human disease
IN2012MN02591A (en)
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
IN2014MN00988A (en)
MX366899B (en) New compounds.
UA109661C2 (en) Pharmaceutical compositions comprising co-crystals of tramadol and celecoxib
PH12017502087B1 (en) Tiotropium inhalation solution for nebulization
MX2013011691A (en) Inhibitors of viral replication, their process of preparation and their therapeutical uses.
WO2014016548A3 (en) Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient
PH12016500814A1 (en) Heteroaryl butanoic acid derivatives
MX2014004196A (en) Rasagiline citramide.
HK1194302A1 (en) Use of pterostilbene for the manufacture of a pharmaceutical composition for the treatment, alleviation, or prevention of anxiety
MX349224B (en) Pharmaceutical composition for use in the treatment of a neurodegenerative disease.
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
WO2013188268A8 (en) Topical ophthalmological pharmaceutical composition containing pazopanib
MX2014002465A (en) Aqueous compositions comprising arbekacin.